These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 20025128)
1. [Role of zonisamid in treating epilepsy, Parkinson disorders and other neurological diseases]. Janszky J Ideggyogy Sz; 2009 Nov; 62(11-12):383-9. PubMed ID: 20025128 [TBL] [Abstract][Full Text] [Related]
2. Novel therapeutic effects of the anti-convulsant, zonisamide, on Parkinson's disease. Murata M Curr Pharm Des; 2004; 10(6):687-93. PubMed ID: 14965331 [TBL] [Abstract][Full Text] [Related]
3. Zonisamide: review of its use in epilepsy therapy. Zareba G Drugs Today (Barc); 2005 Sep; 41(9):589-97. PubMed ID: 16341290 [TBL] [Abstract][Full Text] [Related]
4. [Characteristics and indications of topiramate]. Nieto-Barrera M Rev Neurol; 2002 Sep; 35 Suppl 1():S88-95. PubMed ID: 12373660 [TBL] [Abstract][Full Text] [Related]
5. [Zonisamide in the epilepsy treatment: a literature review from add-on therapy to monotherapy]. Villanueva V; Serrano-Castro PJ Rev Neurol; 2013 Apr; 56(8):429-38. PubMed ID: 23568686 [TBL] [Abstract][Full Text] [Related]
6. Zonisamide in the management of epilepsy in the elderly. Romigi A; Femia EA; Fattore C; Vitrani G; Di Gennaro G; Franco V Clin Interv Aging; 2015; 10():931-7. PubMed ID: 26089654 [TBL] [Abstract][Full Text] [Related]
7. Zonisamide: a new antiepileptic drug. Oommen KJ; Mathews S Clin Neuropharmacol; 1999; 22(4):192-200. PubMed ID: 10442247 [TBL] [Abstract][Full Text] [Related]
8. Zonisamide: a new antiepileptic drug. Sobieszek G; Borowicz KK; Kimber-Trojnar Z; Małek R; Piskorska B; Czuczwar SJ Pol J Pharmacol; 2003; 55(5):683-9. PubMed ID: 14704463 [TBL] [Abstract][Full Text] [Related]
9. [ZONISAMIDE: FIRST CHOICE AMONG THE FIRST-LINE ANTIEPILEPTIC DRUGS IN FOCAL EPILEPSY]. Janszky J; Horvath R; Komoly S Ideggyogy Sz; 2015 May; 68(5-6):149-53. PubMed ID: 26182605 [TBL] [Abstract][Full Text] [Related]
10. Zonisamide has beneficial effects on Parkinson's disease patients. Murata M; Horiuchi E; Kanazawa I Neurosci Res; 2001 Dec; 41(4):397-9. PubMed ID: 11755227 [TBL] [Abstract][Full Text] [Related]
11. [The discovery of an antiparkinsonian drug, zonisamide]. Murata M Rinsho Shinkeigaku; 2010 Feb; 50(2):67-73. PubMed ID: 20196486 [TBL] [Abstract][Full Text] [Related]
12. Zonisamide in the treatment of epilepsy. Holder JL; Wilfong AA Expert Opin Pharmacother; 2011 Nov; 12(16):2573-81. PubMed ID: 21967409 [TBL] [Abstract][Full Text] [Related]
13. Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety. Kothare SV; Kaleyias J Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):493-506. PubMed ID: 18433351 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic role of zonisamide in neuropsychiatric disorders. Farooq MU; Moore PW; Bhatt A; Aburashed R; Kassab MY Mini Rev Med Chem; 2008 Sep; 8(10):968-75. PubMed ID: 18782051 [TBL] [Abstract][Full Text] [Related]
15. Zonisamide in the treatment of epilepsy. Schulze-Bonhage A Expert Opin Pharmacother; 2010 Jan; 11(1):115-26. PubMed ID: 20001433 [TBL] [Abstract][Full Text] [Related]
17. An assessment of zonisamide as an anti-epileptic drug. Jain KK Expert Opin Pharmacother; 2000 Sep; 1(6):1245-60. PubMed ID: 11249491 [TBL] [Abstract][Full Text] [Related]
18. Research advances in basic mechanisms of seizures and antiepileptic drug action. Lasoń W; Chlebicka M; Rejdak K Pharmacol Rep; 2013; 65(4):787-801. PubMed ID: 24145073 [TBL] [Abstract][Full Text] [Related]
19. [Discovery of an antiparkinsonian drug: zonisamide]. Murata M Rinsho Shinkeigaku; 2010 Nov; 50(11):780-2. PubMed ID: 21921440 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of zonisamide: results of a multicenter study. Leppik IE; Willmore LJ; Homan RW; Fromm G; Oommen KJ; Penry JK; Sackellares JC; Smith DB; Lesser RP; Wallace JD Epilepsy Res; 1993 Feb; 14(2):165-73. PubMed ID: 8453952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]